Severe airway hyperresponsiveness was not predictable with the use of current tools in asthmatic children in general practice

Journal of Clinical Epidemiology

Volumn 60, Issue 10, 2007, Pages 1052-1059

  Hagmolen of ten Have, W ^a,b   van den Berg, N J ^a,b   van der Palen, J ^c   van Aalderen, W M C ^b   Bindels, P J E ^d  

^a Flevo Hospital   (Netherlands)

^b EMMA CHILDREN S HOSPITAL   (Netherlands)

^c MEDISCH SPECTRUM TWENTE   (Netherlands)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Adolescent; Asthma; Bronchial hyperreactivity; Child; Family Practice; Regression analysis

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; METHACHOLINE;

ADOLESCENT; ALLERGY; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CONTROLLED STUDY; DYSPNEA; ENVIRONMENTAL FACTOR; FEMALE; FORCED EXPIRATORY VOLUME; GENERAL PRACTICE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION SYSTEM; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; RESPIRATORY TRACT ALLERGY; SCHOOL CHILD; WHEEZING;

ADOLESCENT; ADRENERGIC BETA-AGONISTS; ANTI-ASTHMATIC AGENTS; ASTHMA; BRONCHIAL HYPERREACTIVITY; BRONCHIAL PROVOCATION TESTS; CHILD; CROSS-SECTIONAL STUDIES; DRUG ADMINISTRATION SCHEDULE; FAMILY PRACTICE; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; PATIENT SELECTION; PEAK EXPIRATORY FLOW RATE; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 34548614312     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2007.01.013     Document Type: Article

References (33)

1. Bousquet J., Jeffery P.K., Busse W.W., Johnson M., and Vignola A.M. Asthma. From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med 161 (2000) 1720-1745
2. Dirksen W.J., Geijer R.M.M., de Haan M., de Koning G., Flikweert S., Kolnaar B.G.M., et al. NHG-Standaard: astma in kinderen. Huisarts Wet 41 (1998) 130-143
3. NHLBI, WHO, NIH. Global Initiative for Asthma: workshop report. Global strategy for asthma management and prevention (2005 update). NIH publication no. 02-3659; 2005.
4. NIH, NHLBI. Global Inititative for Asthma (GINA). Global strategy for asthma management and prevention. NHLBI/WHO workshop report (1995), NIH publication
5. Rabe K.F., Vermeire P.A., Soriano J.B., and Maier W.C. Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. Eur Respir J 16 (2000) 802-807
6. Maziak W., von Mutius E., Beimfohr C., Hirsch T., Leupold W., Keil U., et al. The management of childhood asthma in the community. Eur Respir J 20 (2002) 1476-1482
7. Rabe K.F., Adachi M., Lai C.K., Soriano J.B., Vermeire P.A., Weiss K.B., et al. Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys. J Allergy Clin Immunol 114 (2004) 40-47
8. Agertoft L., and Pedersen S. Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. Respir Med 88 (1994) 373-381
9. Grol M.H., Gerritsen J., Vonk J.M., Schouten J.P., Koeter G.H., Rijcken B., et al. Risk factors for growth and decline of lung function in asthmatic individuals up to age 42 years. A 30-year follow-up study. Am J Respir Crit Care Med 160 (1999) 1830-1837
10. Rasmussen F., Taylor D.R., Flannery E.M., Cowan J.O., Greene J.M., Herbison G.P., et al. Risk factors for airway remodeling in asthma manifested by a low postbronchodilator FEV1/vital capacity ratio: a longitudinal population study from childhood to adulthood. Am J Respir Crit Care Med 165 (2002) 1480-1488
11. James A.L., Palmer L.J., Kicic E., Maxwell P.S., Lagan S.E., Ryan G.F., et al. Decline in lung function in the Busselton Health Study: the effects of asthma and cigarette smoking. Am J Respir Crit Care Med 171 (2005) 109-114
12. Sont J.K., Willems L.N., Bel E.H., van Krieken J.H., Vandenbroucke J.P., and Sterk P.J. Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group. Am J Respir Crit Care Med 159 (1999) 1043-1051
13. Hagmolen of ten Have W., Van den Berg N.J., van der Palen J., Bindels P.J., and van Aalderen W.M. Validation of a Single Concentration Methacholine Inhalation Provocation Test (SCIPT) in children. J Asthma 42 (2005) 419-423
14. Henderson A.R. The bootstrap: a technique for data-driven statistics. Using computer-intensive analyses to explore experimental data. Clin Chim Acta 359 (2005) 1-26
15. Kamps A.W., Roorda R.J., and Brand P.L. Peak flow diaries in childhood asthma are unreliable. Thorax 56 (2001) 180-182
16. Meijer G.G., Postma D.S., Wempe J.B., Gerritsen J., Knol K., and van Aalderen W.M. Frequency of nocturnal symptoms in asthmatic children attending a hospital out-patient clinic. Eur Respir J 8 (1995) 2076-2080
17. van Aalderen W.M., Postma D.S., Koeter G.H., and Knol K. Circadian change in bronchial responsiveness and airflow obstruction in asthmatic children. Thorax 44 (1989) 803-807
18. Weersink E.J., van Zomeren E.H., Koeter G.H., and Postma D.S. Treatment of nocturnal airway obstruction improves daytime cognitive performance in asthmatics. Am J Respir Crit Care Med 156 (1997) 1144-1150
19. Gibson P.G., Mattoli S., Sears M.R., Dolovich J., and Hargreave F.E. Increased peak flow variability in children with asymptomatic hyperresponsiveness. Eur Respir J 8 (1995) 1731-1735
20. Trigg C.J., Bennett J.B., Tooley M., Sibbald B., D'Souza M.F., and Davies R.J. A general practice based survey of bronchial hyperresponsiveness and its relation to symptoms, sex, age, atopy, and smoking. Thorax 45 (1990) 866-872
21. Brand P.L., Duiverman E.J., Waalkens H.J., van Essen-Zandvliet E.E., and Kerrebijn K.F. Peak flow variation in childhood asthma: correlation with symptoms, airways obstruction, and hyperresponsiveness during long-term treatment with inhaled corticosteroids. Dutch CNSLD Study Group. Thorax 54 (1999) 103-107
22. Higgins B.G., Britton J.R., Chinn S., Cooper S., Burney P.G., and Tattersfield A.E. Comparison of bronchial reactivity and peak expiratory flow variability measurements for epidemiologic studies. Am Rev Respir Dis 145 (1992) 588-593
23. Tepas E.C., Litonjua A.A., Celedon J.C., Sredl D., and Gold D.R. Sensitization to aeroallergens and airway hyperresponsiveness at 7 years of age. Chest 129 (2006) 1500-1508
24. Wong G.W., Li S.T., Hui D.S., Fok T.F., Zhong N.S., Chen Y.Z., et al. Individual allergens as risk factors for asthma and bronchial hyperresponsiveness in Chinese children. Eur Respir J 19 (2002) 288-293
25. Burrows B. Allergy and the development of asthma and bronchial hyperresponsiveness. Clin Exp Allergy 25 (1995) 15-16
26. Sears M.R., Burrows B., Herbison G.P., Holdaway M.D., and Flannery E.M. Atopy in childhood. II. Relationship to airway responsiveness, hay fever and asthma. Clin Exp Allergy 23 (1993) 949-956
27. Toelle B.G., Peat J.K., Salome C.M., Mellis C.M., and Woolcock A.J. Toward a definition of asthma for epidemiology. Am Rev Respir Dis 146 (1992) 633-637
28. Clifford R.D., Radford M., Howell J.B., and Holgate S.T. Prevalence of atopy and range of bronchial response to methacholine in 7 and 11 year old schoolchildren. Arch Dis Child 64 (1989) 1126-1132
29. Covar R.A., Spahn J.D., Murphy J.R., and Szefler S.J. Progression of asthma measured by lung function in the childhood asthma management program. Am J Respir Crit Care Med 170 (2004) 234-241
30. Pauwels R.A., Pedersen S., Busse W.W., Tan W.C., Chen Y.Z., Ohlsson S.V., et al. Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial. Lancet 361 (2003) 1071-1076
31. Xuan W., Peat J.K., Toelle B.G., Marks G.B., Berry G., and Woolcock A.J. Lung function growth and its relation to airway hyperresponsiveness and recent wheeze. Results from a longitudinal population study. Am J Respir Crit Care Med 161 (2000) 1820-1824
32. Rijcken B., Schouten J.P., Xu X., Rosner B., and Weiss S.T. Airway hyperresponsiveness to histamine associated with accelerated decline in FEV1. Am J Respir Crit Care Med 151 (1995) 1377-1382
33. Sherrill D., Sears M.R., Lebowitz M.D., Holdaway M.D., Hewitt C.J., Flannery E.M., et al. The effects of airway hyperresponsiveness, wheezing, and atopy on longitudinal pulmonary function in children: a 6-year follow-up study. Pediatr Pulmonol 13 (1992) 78-85